Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2022 - 03 - 03 save search
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Published: 2022-03-03 (Crawled : 23:00) - biospace.com/
OTLC | $0.042 -44.63% 100K
|
Manufacturing
|
| O: -3.8%
H: 3.95%
C: 3.95%
arcus
Regulus Therapeutics Announces Timing for Fourth Quarter and Year-End 2021 Financial Results Webcast and Conference Call
Published: 2022-03-03 (Crawled : 23:00) - prnewswire.com
RGLS | $2.13 -4.05% -4.23% 220K
|
Health Technology
|
| O: -1.0%
H: 8.85%
C: 2.2%
financial results conference therapeutics results
Viridian Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Investor Conference Call on March 10, 2022
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M
|
Health Care and Social Assistan...
|
| O: 2.25%
H: 2.54%
C: -2.25%
financial results conference therapeutics report results
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
Published: 2022-03-03 (Crawled : 22:00) - biospace.com/
RAIN | $1.21 0.0% 3.7M
|
Manufacturing
|
| O: 2.9%
H: 0.0%
C: -10.76%
financial results therapeutics report results
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
Published: 2022-03-03 (Crawled : 22:00) - globenewswire.com
TVTX | $5.73 -1.21% -1.22% 950K
|
Health Technology
|
| O: -0.75%
H: 2.57%
C: -0.72%
health thc conference therapeutics
MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update
Published: 2022-03-03 (Crawled : 22:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: 1.71%
H: 3.99%
C: -2.02%
financial results therapeutics report results
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 22:00) - globenewswire.com
CLLS | $2.47 0.4% 12K
|
Health Technology
|
| O: -0.53%
H: 5.04%
C: -6.37%
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: -1.16%
H: 2.41%
C: -5.41%
financial results cel report results
Praluzatamab Ravtansine, a CD166-Targeting Antibody– Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial
Published: 2022-03-03 (Crawled : 21:00) - cytomx.com
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: -1.57%
H: 2.66%
C: -1.33%
cd166 solid tumors cd16 drug trial label antibody
Sensei Biotherapeutics to Participate in the 32nd Annual Oppenheimer Healthcare Conference
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
SNSE | $1.03 4.79% 4.57% 24K
|
|
| O: -1.49%
H: 3.86%
C: -3.93%
health thc conference therapeutics iot
Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.0%
H: 1.15%
C: 0.38%
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -1.71%
H: 10.39%
C: 7.24%
therapeutics financial results report results
Seres Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: 1.14%
H: 0.13%
C: -7.57%
health conference therapeutics
CytoImmune Therapeutics to Participate in the Cowen's 42nd Annual Health Care Conference
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: 40.0%
H: 1.14%
C: -18.86%
health conference therapeutics
Fulcrum Therapeutics® Announces REACH, a Phase 3 Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
Published: 2022-03-03 (Crawled : 20:00) - biospace.com/
FULC | $6.86 -2.83% -2.92% 560K
|
Health Technology
|
| O: -1.71%
H: 10.39%
C: 7.24%
therapeutics muscular dystrophy trial phase 3
Better Therapeutics Sponsors Educational Symposium on the Use of Software as a Next-Generation Treatment for Cardiometabolic Diseases
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
BTTX | $0.009 -65.02% 180K
|
|
| O: 0.0%
H: 3.46%
C: -3.08%
treatment symposium metabolic cardio therapeutics disease education software pons
Capricor Therapeutics to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on March 10Company to Host Conference Call, March 10, 2022, at 4:30 p.m. ET
Published: 2022-03-03 (Crawled : 17:00) - biospace.com/
CAPR | $5.01 -0.79% -0.8% 350K
|
Health Technology
|
| O: 3.45%
H: 2.89%
C: 0.67%
financial results conference therapeutics results
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
Published: 2022-03-03 (Crawled : 15:00) - globenewswire.com
INKT | $0.898 3.02% 2.93% 40K
|
|
| O: -0.35%
H: 8.8%
C: 2.82%
therapeutics cel therapy cancer
Tango Therapeutics Announces Presentation of TNG908 Preclinical Combination Data at 2022 ESMO Targeted Anticancer Therapies Congress
Published: 2022-03-03 (Crawled : 15:00) - globenewswire.com
TNGX | $7.33 -0.54% -0.55% 530K
|
|
| O: 0.74%
H: 0.0%
C: -8.1%
tng908 therapeutics presentation preclinical cancer therapy pre-clinical
Capricor Therapeutics to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on March 10
Published: 2022-03-03 (Crawled : 14:30) - globenewswire.com
CAPR | $5.01 -0.79% -0.8% 350K
|
Health Technology
|
| O: 3.45%
H: 2.89%
C: 0.67%
financial results therapeutics results
Aquestive Therapeutics and Haisco Pharmaceutical Group Enter Licensing and Supply Agreement for Riluzole Oral Film for ALS Treatment in China
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
AQST | $4.11 -8.67% -9.49% 2.3M
|
Health Technology
|
| O: 5.54%
H: 4.59%
C: -0.33%
treatment als therapeutics china group license riluzole
VYNE Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
VYNE | $2.285 -0.65% -0.66% 19K
|
Health Technology
|
| O: -2.27%
H: 0.0%
C: 0.0%
health thc conference therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.